NewcelX Announces $1.55 Million Private Placement to Fund Diabetes Program
NewcelX (NCEL) has priced a private placement offering totaling $1.55 million at $3.29 per share. This pricing represents a 20% premium over the company's closing price on November 6. The capital raise consists of 471,125 common shares and includes warrants for an additional 353,344 shares. The proceeds from this offering are specifically earmarked to fund the company's ongoing diabetes research and development program.
Tickers: $NCEL.IL